- GlobeNewswire•1 hour agoCytori to Acquire Proprietary Nanoparticle Development Platform to Enhance Regenerative Medicine Leadership Position
Proposed Acquisition of Azaya Therapeutics Assets Would Broaden Pipeline with Two Oncology Drugs for Large, Underserved Markets. SAN DIEGO, Jan. 19, 2017-- Cytori Therapeutics, Inc. today announced it ...
- GlobeNewswire•9 days agoCytori to Expand Scleroderma Focus to Broader Hand Therapy Franchise Under the Habeo™ Cell Therapy Brand
SAN DIEGO, Jan. 10, 2017-- Cytori Therapeutics, Inc., as part of its corporate update at the Biotech Showcase, announced its intention to broaden its investigation of the ECCS-50 formulation of Cytori ...
- GlobeNewswire•13 days ago
SAN DIEGO, Jan. 06, 2017-- Cytori Therapeutics, Inc. announced today that the company will present at the Biotech Showcase™ at 4:00 PM Pacific Time on Tuesday, January 10, 2017. The presentation will take ...
CYTX : Summary for Cytori Therapeutics Inc - Yahoo Finance
Cytori Therapeutics, Inc. (CYTX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||1.81 x 200|
|Ask||1.90 x 600|
|Day's Range||1.46 - 1.68|
|52 Week Range||1.36 - 5.40|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1.23|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|